Terms: = Uterine cancer AND HRAS, K-ras, 3265, ENSG00000174775, HRAS1, RASH1, c-bas/has, P01112, N-ras AND Treatment
40 results:
1. Integrating network pharmacology approaches for the investigation of multi-target pharmacological mechanism of 6-shogaol against cervical cancer.
Elasbali AM; Al-Soud WA; Mousa Elayyan AE; Al-Oanzi ZH; Alhassan HH; Mohamed BM; Alanazi HH; Ashraf MS; Moiz S; Patel M; Patel M; Adnan M
J Biomol Struct Dyn; 2023; 41(23):14135-14151. PubMed ID: 36943780
[TBL] [Abstract] [Full Text] [Related]
2. Acquisition of Genetic Aberrations During the Progression of High-Grade Intraepithelial Lesions/Micro-Invasive Squamous cancers to Widely Invasive Cervical Squamous Cell cancer.
Kashofer K; Reich O; Regauer S
Arch Pathol Lab Med; 2023 Dec; 147(12):1438-1445. PubMed ID: 36800542
[TBL] [Abstract] [Full Text] [Related]
3. Biomolecular and Genetic Prognostic Factors That Can Facilitate Fertility-Sparing treatment (FST) Decision Making in Early Stage Endometrial cancer (ES-EC): A Systematic Review.
Tanos P; Dimitriou S; Gullo G; Tanos V
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269800
[TBL] [Abstract] [Full Text] [Related]
4. Expression of miR-34a and miR-15b during the progression of cervical cancer in a murine model expressing the HPV16 E7 oncoprotein.
Ocadiz-Delgado R; Cruz-Colin JL; Alvarez-Rios E; Torres-Carrillo A; Hernandez-Mendoza K; Conde-Pérezprina JC; Dominguez-Gomez GI; Garcia-Villa E; Lambert PF; Gariglio P
J Physiol Biochem; 2021 Nov; 77(4):547-555. PubMed ID: 33937961
[TBL] [Abstract] [Full Text] [Related]
5. Ovarian mucinous tumors with mural nodules: immunohistochemical and molecular analysis of 3 cases.
Shao Y; Liu Q; Shi H; Lu B
Diagn Pathol; 2020 Apr; 15(1):35. PubMed ID: 32290854
[TBL] [Abstract] [Full Text] [Related]
6. Comparison of laparoscopic and abdominal radical hysterectomy in early stage cervical cancer patients without adjuvant treatment: Ancillary analysis of a Korean Gynecologic Oncology Group Study (KGOG 1028).
Paik ES; Lim MC; Kim MH; Kim YH; Song ES; Seong SJ; Suh DH; Lee JM; Lee C; Choi CH
Gynecol Oncol; 2019 Sep; 154(3):547-553. PubMed ID: 31272738
[TBL] [Abstract] [Full Text] [Related]
7. Establishment and characterization of cell lines derived from complete hydatidiform mole.
Yamamoto E; Niimi K; Kiyono T; Yamamoto T; Nishino K; Nakamura K; Kotani T; Kajiyama H; Shibata K; Kikkawa F
Int J Mol Med; 2017 Sep; 40(3):614-622. PubMed ID: 28713902
[TBL] [Abstract] [Full Text] [Related]
8. An integrated approach of network-based systems biology, molecular docking, and molecular dynamics approach to unravel the role of existing antiviral molecules against AIDS-associated cancer.
Omer A; Singh P
J Biomol Struct Dyn; 2017 May; 35(7):1547-1558. PubMed ID: 27484103
[TBL] [Abstract] [Full Text] [Related]
9. Phase I trial evaluating the antiviral agent Cidofovir in combination with chemoradiation in cervical cancer patients.
Deutsch E; Haie-Meder C; Bayar MA; Mondini M; Laporte M; Mazeron R; Adam J; Varga A; Vassal G; Magné N; Chargari C; Lanoy E; Pautier P; Levy A; Soria JC
Oncotarget; 2016 May; 7(18):25549-57. PubMed ID: 27016411
[TBL] [Abstract] [Full Text] [Related]
10. Surgical treatment of high stage endometrial cancer: current perspectives.
Vitale SG; Valenti G; Gulino FA; Cignini P; Biondi A
Updates Surg; 2016 Jun; 68(2):149-54. PubMed ID: 26826083
[TBL] [Abstract] [Full Text] [Related]
11. Gamma tocotrienol targets tyrosine phosphatase SHP2 in mammospheres resulting in cell death through RAS/ERK pathway.
Gu W; Prasadam I; Yu M; Zhang F; Ling P; Xiao Y; Yu C
BMC Cancer; 2015 Aug; 15():609. PubMed ID: 26315028
[TBL] [Abstract] [Full Text] [Related]
12. k-ras stabilization by estrogen via PKCδ is involved in endometrial tumorigenesis.
Koo KH; Jeong WJ; Cho YH; Park JC; Min do S; Choi KY
Oncotarget; 2015 Aug; 6(25):21328-40. PubMed ID: 26015399
[TBL] [Abstract] [Full Text] [Related]
13. Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative.
Stelloo E; Bosse T; Nout RA; MacKay HJ; Church DN; Nijman HW; Leary A; Edmondson RJ; Powell ME; Crosbie EJ; Kitchener HC; Mileshkin L; Pollock PM; Smit VT; Creutzberg CL
Mod Pathol; 2015 Jun; 28(6):836-44. PubMed ID: 25720322
[TBL] [Abstract] [Full Text] [Related]
14. Carcinogenic mechanisms of endometrial cancer: involvement of genetics and epigenetics.
Banno K; Yanokura M; Iida M; Masuda K; Aoki D
J Obstet Gynaecol Res; 2014 Aug; 40(8):1957-67. PubMed ID: 25131761
[TBL] [Abstract] [Full Text] [Related]
15. Another surprise from Metformin: novel mechanism of action via k-ras influences endometrial cancer response to therapy.
Iglesias DA; Yates MS; van der Hoeven D; Rodkey TL; Zhang Q; Co NN; Burzawa J; Chigurupati S; Celestino J; Bowser J; Broaddus R; Hancock JF; Schmandt R; Lu KH
Mol Cancer Ther; 2013 Dec; 12(12):2847-56. PubMed ID: 24077915
[TBL] [Abstract] [Full Text] [Related]
16. Endometrial carcinomas with significant mucinous differentiation associated with higher frequency of k-ras mutations: a morphologic and molecular correlation study.
Xiong J; He M; Jackson C; Ou JJ; Sung CJ; Breese V; Steinhoff MM; Quddus MR; Tejada-Berges T; Lawrence WD
Int J Gynecol Cancer; 2013 Sep; 23(7):1231-6. PubMed ID: 23851676
[TBL] [Abstract] [Full Text] [Related]
17. Predicting everolimus treatment efficacy in patients with advanced endometrial carcinoma: a GINECO group study.
Trédan O; Treilleux I; Wang Q; Gane N; Pissaloux D; Bonnin N; Petit T; Cretin J; Bonichon-Lamichhane N; Priou F; Lavau-Denes S; Mari V; Freyer G; Lebrun D; Alexandre J; Ray-Coquard I
Target Oncol; 2013 Dec; 8(4):243-51. PubMed ID: 23238879
[TBL] [Abstract] [Full Text] [Related]
18. k-ras resides on the Arf6-mediated CIE system and its active type interacted with Arf6T27N.
Xie CG; Wei SM; Cai JT
Cell Signal; 2012 Feb; 24(2):524-531. PubMed ID: 22033036
[TBL] [Abstract] [Full Text] [Related]
19. Establishment of a choriocarcinoma model from immortalized normal extravillous trophoblast cells transduced with hrasV12.
Kobayashi Y; Shimizu T; Naoe H; Ueki A; Ishizawa J; Chiyoda T; Onishi N; Sugihara E; Nagano O; Banno K; Kuninaka S; Aoki D; Saya H
Am J Pathol; 2011 Sep; 179(3):1471-82. PubMed ID: 21787741
[TBL] [Abstract] [Full Text] [Related]
20. Genetic alterations in the k-ras gene influence the prognosis in patients with cervical cancer treated by radiotherapy.
Wegman P; Ahlin C; Sorbe B
Int J Gynecol Cancer; 2011 Jan; 21(1):86-91. PubMed ID: 21330833
[TBL] [Abstract] [Full Text] [Related]
[Next]
